Glycorex Transplantation AB

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: SE0000524530

SEK

1.50

0.2 (15.44%)

Mar 26

NGM

View all stocks in this country

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Q-linea AB

Glycorex Transplantation AB

Boule Diagnostics AB

Episurf Medical AB

Dignitana AB

Clinical Laserthermia Systems AB

Corline Biomedical AB

SciBase Holding AB

Redsense Medical AB

Lumito AB

Irras AB

Why is Glycorex Transplantation AB ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Glycorex Transplantation AB for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Glycorex Transplantation AB

-27.78%

1.19

113.85%

OMX Stockholm 30

10.97%

0.24

18.06%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

7.54%

EBIT Growth (5y)

3.80%

EBIT to Interest (avg)

-14.91

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.27

Sales to Capital Employed (avg)

4.58

Tax Ratio

0.67%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

3.87

EV to EBIT

-19.27

EV to EBITDA

74.01

EV to Capital Employed

4.74

EV to Sales

3.79

PEG Ratio

Dividend Yield

ROCE (Latest)

-24.61%

ROE (Latest)

-20.29%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bullish

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

11What is working for the Company

OPERATING CASH FLOW(Y)

Highest at SEK 2.03 MM

NET PROFIT(HY)

Higher at SEK -3.38 MM

ROCE(HY)

Highest at -19.51%

RAW MATERIAL COST(Y)

Fallen by -43.18% (YoY

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Here's what is working for Glycorex Transplantation AB

Operating Cash Flow

Highest at SEK 2.03 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (SEK MM)

Net Profit

Higher at SEK -3.38 MM

than preceding 12 month period ended Sep 2025

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (SEK MM)

Raw Material Cost

Fallen by -43.18% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation

Highest at SEK 2.37 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (SEK MM)